Coralville-based SynderBio was awarded the top company award at this year's Partnering For Growth Biotech Innovation Showcase held in Ankeny on Tuesday.
Welcome to the University of Iowa Research Park, where collaborative opportunities in technology abound.
We offer corporations locating at the Park convenient, sustained access to the extensive, relevant research resources of The University of Iowa.
Here, growing enterprises have access to a state-of-the art business incubator, world-class research facilities and a dynamic faculty of scientists, physicians and engineers at one of the world’s leading public research universities.
News & Announcements
THIS MARKS THE FIFTH YEAR THAT MEDIREVV HAS BEEN RANKED IN THE TOP THREE!
Coralville, IA – February 28, 2018– MediRevv, a healthcare revenue cycle management company, has been ranked second in the “Extended Business Office” category of the 2017/2018 Best in KLAS: Software and Services Report, February 2018.
MediRevv debuted on the KLAS list in 2013/2014 ranking third. In the 2014/2015 Best in KLAS report, they moved into the second position for the first time. Of note, MediRevv has held the second place ranking for four years running.
CORALVILLE, Iowa, Feb. 23, 2018 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ:KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, announced today that the U.S. Food and Drug Administration (FDA) approved its New Drug Application (NDA) for Apadaz™ for the short-term (no more than 14 days) management of acute pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Apadaz is an immediate release (IR) combination of KemPharm’s prodrug, benzhydrocodone, and acetaminophen (APAP).